Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)

INR 1805.85

(0.31%)

Market Cap (In INR)

4332.73 Billion

Revenue (In INR)

484.96 Billion

Net Income (In INR)

95.76 Billion

Avg. Volume

77.5 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1209.0-1960.2
PE
-
EPS
-
Beta Value
0.547
ISIN
INE044A01036
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Dilip Shantilal Shanghvi
Employee Count
-
Website
https://www.sunpharma.com
Ipo Date
2000-01-03
Details
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

More Stocks